RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (IST:RTALB)
3.510
-0.150 (-4.10%)
At close: Mar 27, 2026
IST:RTALB Balance Sheet
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.7 | 8.52 | 47.16 | 51.68 | 157.54 |
Trading Asset Securities | 5.75 | 5.85 | 101.2 | 194.57 | 5.86 |
Cash & Short-Term Investments | 10.45 | 14.38 | 148.36 | 246.24 | 163.4 |
Cash Growth | -27.30% | -90.31% | -39.75% | 50.70% | 788.97% |
Accounts Receivable | 95.5 | 78.92 | 60.93 | 82.13 | 103.66 |
Other Receivables | 9.71 | 14.04 | 1.99 | 78.97 | 37.61 |
Receivables | 105.21 | 92.96 | 62.92 | 161.1 | 141.27 |
Inventory | 42.14 | 53.49 | 67.59 | 50.06 | 22.88 |
Prepaid Expenses | 0.04 | 0.71 | 0.85 | 1.25 | 0 |
Other Current Assets | 27.47 | 41.39 | 80.01 | 52.06 | 41.83 |
Total Current Assets | 185.31 | 202.93 | 359.73 | 510.72 | 369.39 |
Property, Plant & Equipment | 388.79 | 374.78 | 211.47 | 167.21 | 46.75 |
Long-Term Investments | 2,664 | 1,809 | 1,186 | 640.9 | 128.72 |
Other Intangible Assets | 0.01 | 0.17 | 0.44 | 1.74 | 0.56 |
Long-Term Deferred Tax Assets | - | 65.86 | - | - | - |
Other Long-Term Assets | 195.48 | 61.71 | 47.01 | 21.94 | 6.98 |
Total Assets | 3,434 | 2,515 | 1,805 | 1,343 | 552.4 |
Accounts Payable | 25.03 | 26.76 | 50.24 | 18.37 | 101.27 |
Accrued Expenses | 5.97 | 4.1 | 2.48 | 1.98 | 2.48 |
Short-Term Debt | 83.3 | 216.1 | 44.55 | 64.03 | 54.72 |
Current Portion of Long-Term Debt | 15.7 | 30.54 | 18.34 | 46.49 | 0.4 |
Current Portion of Leases | 3.46 | 3.17 | 0.59 | 0.59 | 0.26 |
Current Income Taxes Payable | - | - | - | - | 14.32 |
Current Unearned Revenue | 0.42 | 0.22 | 11.77 | 14.3 | 31.34 |
Other Current Liabilities | 0.32 | 0.63 | 0.28 | 0.27 | 0.09 |
Total Current Liabilities | 134.2 | 281.51 | 128.24 | 146.04 | 204.88 |
Long-Term Debt | 14.86 | 39.07 | 0.99 | 2.6 | 0.31 |
Long-Term Leases | 1.8 | 4.01 | 2.54 | 1.35 | 0.27 |
Pension & Post-Retirement Benefits | 4.55 | 5.49 | 2.34 | 2.35 | 0.38 |
Long-Term Deferred Tax Liabilities | 313.46 | - | 53.65 | 56.53 | 3.33 |
Total Liabilities | 468.87 | 330.07 | 187.77 | 208.86 | 209.17 |
Common Stock | 500 | 100 | 100 | 100 | 42.97 |
Additional Paid-In Capital | 209.18 | 209.18 | 159.81 | 110.69 | 52.88 |
Retained Earnings | 1,822 | 1,100 | 788.35 | 490.6 | 207.63 |
Comprehensive Income & Other | 433.97 | 775.15 | 568.62 | 362.29 | 9.19 |
Total Common Equity | 2,965 | 2,185 | 1,617 | 1,064 | 312.67 |
Minority Interest | - | - | - | 70.07 | 30.56 |
Shareholders' Equity | 2,965 | 2,185 | 1,617 | 1,134 | 343.23 |
Total Liabilities & Equity | 3,434 | 2,515 | 1,805 | 1,343 | 552.4 |
Total Debt | 119.12 | 292.88 | 67.01 | 115.07 | 55.96 |
Net Cash (Debt) | -108.67 | -278.5 | 81.36 | 131.17 | 107.44 |
Net Cash Growth | - | - | -37.98% | 22.09% | - |
Net Cash Per Share | -0.22 | -0.56 | 0.16 | 0.26 | 0.21 |
Filing Date Shares Outstanding | 500 | 500 | 500 | 500 | 500 |
Total Common Shares Outstanding | 500 | 500 | 500 | 500 | 500 |
Working Capital | 51.11 | -78.58 | 231.49 | 364.68 | 164.51 |
Book Value Per Share | 5.93 | 4.37 | 3.23 | 2.13 | 0.63 |
Tangible Book Value | 2,965 | 2,184 | 1,616 | 1,062 | 312.11 |
Tangible Book Value Per Share | 5.93 | 4.37 | 3.23 | 2.12 | 0.62 |
Land | 126.99 | 71.99 | 11.27 | 11.07 | 6.72 |
Buildings | 103.07 | 153.17 | 69.78 | 34.89 | 3.06 |
Machinery | 358.38 | 321.48 | 225.62 | 197.82 | 42.41 |
Construction In Progress | - | 26.11 | 44.85 | 27.92 | 4.83 |
Leasehold Improvements | 0.36 | 0.36 | 0.28 | - | 0.16 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.